Objective: To determine the ultrastructural findings on Rectal Mucosa (RM) of patients with HIV/AIDS and anorectal pathologies (ARP), at micrometric and nanometric scales. Materials and methods: 5 patients were evaluated, 18 -55 years old, with ARP (HIV co-infection with HPV, n = 4, and HIV-negative patient with HPV infection) (control n = 1), who were referred to the Coloproctology Unit of the HUC, and subjected to rectoscopy and biopsy. RM samples were identified, placed in a sterile plastic bottle with 1 mL of 2% glutaraldehyde and immediately transported for routine processing of fine cut (60 -90 nm) to be evaluated via Transmission Electron Microscopy (TEM). They were fixed with Karnovsky solution with Millonig phosphate buffer (pH 7.4 and 320 mOsm) and post-fixed with OsO 4 under the same conditions of pH and osmolarity. Results: Ultrastructural findings, at 10 
Introduction
Gastrointestinal pathologies/disorders (GI) are common during the course of HIV infection. 35% of patients have GI symptoms as clinical presentation of HIV. These are usually very varied and include weight loss, dysphagia, anorexia, gastric disorders and diarrhea, the latter being one of the most common symptoms occurring in 30% to 50% of patients in North America and Europe [1] [2] .
Affectation that produces HIV along the digestive tract may compromise the mouth, esophagus, stomach, small intestine, colon and terminal portions as anus and rectum [3] [4] [5] . Among the most frequent anorectal diseases, the following have been reported: condyloma acuminata (human papilloma virus [HPV] ), fistulas, perianal abscesses, hemorrhoids, fissures, perianal herpes, nonspecific proctitis, rectal masses (polyps, diverticula, Kaposi's sarcoma). Opportunistic and neoplastic anal and rectal infections have also been described in these patients, with a variety of symptoms that can range from anorectal pain, tenesmus and discharge from the rectum [6] [7] [8] .
The intestinal mucosa (IM) plays an important role in the pathogenesis as well as a persistent HIV area despite the fact that Highly Active Antiretroviral Therapy (HAART) is effective [9] [10] . The rectal mucosa (RM) is the main gateway into groups of men who have sex with men (MSM). The virus can penetrate by direct trauma of the RM, after which it has access to the microcirculation, however, even without existing trauma, HIV can penetrate the RM by viral absorption through specialized epithelial cells called M present in the epithelium associated follicles [10] , by transcytosis across epithelial cells or by direct sampling of dendritic cells from the lamina propia. HIV temporarily may open tight junctions between epithelial cells generating a gradient that drives viral migration of dendritic cells through R5 receptor [11] . In addition, the IM contains a high percentage of cells that are the main target of HIV and represents the ideal site of viral replication and depletion of CD4+ T cells [12] [13] . Previous research has shown that viral replication remains in lymphoid tissue for at least two years despite the fact that HAART has achieved complete suppression of viral load in peripheral blood. This also demonstrates incomplete suppression of [14] . It is relevant to notice an important finding which is the existence of efflux pumps that are expressed in the intestinal epithelium called P glycoprotein-1 (P-gp), which eject different substances outside the cells and carrying various substrates across the cell membrane including antiretroviral drugs as protease inhibitors (PI) and non-nucleoside inhibitors of reverse transcriptase (NNIRT). Increased expression of intestinal P-gp may reduce the absorption of drugs that are substrates of P-gp and may result in reduced bioavailability and subtherapeutic plasma levels [15] . Transmission Electron microscopy studies have detected the presence of the virus and changes in the lymphoid composition in IM with depletion of T lymphocytes [16] [17] . GI disorders caused by HIV are due in part to the presence of opportunistic pathogens or hidden enteric infections, due to indirect effects of HIV on the intestinal epithelium or to indirect secondary effects of immunological abnormalities in the absence of enteric pathogens unidentifiable (e.g.: lysing infected cells expressing viral proteins on their surface); as well as injury or damage of the intestinal mucosa by direct cytopathic effect [17] [18] [19] .
In this specific research, we evaluate the ultrastructural findings, at micrometric and nanometric scales, in rectal and muscular mucosa of patients with HIV/AIDS and anorectal pathologies in order to achieve a better understanding of this pathology and a therapeutic directed to target with perspectives to upgrade the quality of life.
Objective: To determine the ultrastructural findings on RM of patients with HIV/AIDS and ARP, at micrometric and nanometric scales. 
Materials and Methods

Results
The characteristics of the patients who participated in the study are described in the following table: [8] . In this specific study it was evidenced, at the ultrastructural level, inflammation of nuclear envelopes and cytoplasmic organelles (mitochondria and RER) as well as edema in some areas of association with axon terminals.
Pérez-Matute et al. stated that: "Several factors can affect the functionality of the mitochondria, (inter alia), aging, infections or certain medications used to treat HIV/AIDS. Nucleotide reverse transcriptase inhibitors (NRTIs) have been considered as the main source of mitochondrial toxicity related to HAART, since these can inhibit Pol-γ, the DNA polymerase responsible for the synthesis of mitochondrial DNA, although non-nucleoside transcriptase inhibitors (NNRTI) or protease inhibitors (PI) they have also shown mitochondrial toxicity" (Pérez-Matute P et al., 2013) [24] . In this study, the following findings were found, via electron microscopy, at the level of the mitochondria, namely, swelling of mitochondria at the level of smooth muscle cell of mucosa and paracrystalline inclusions that are formed starting from the cytochromes of the internal membrane when the integrity of the mitochondrial cristae are lost.
Mergia Ayalew (2017) [25] , described that: It is evident that there are many challenges to research which will allow a bet-
ter understanding of what takes place at the molecular level of the IM. This is with the objective of uncovering the target that could optimize the penetration of nano-drugs able to eradicate HIV in those sites of the intestine where conventional antiretroviral have restricted access. Another of the challenges is to achieve that nano-ART could pass the regulatory barrier expeditiously, demonstrating its efficacy, safety and a good balance risk/benefit for its approval and could be available to the medical community in general.
Conclusions
These results point to the fact that HIV causes visible changes, at micrometric and nanometric scales, in the rectal mucosa despite the fact that HAART has achieved complete suppression of viral load in peripheral blood. All these above captioned alterations can generate intestinal and anorectal dysfunction in these patients. The decreasing of Caveolae or their absence in some areas in the membrane of the endothelial cell may produce alteration of the cellular processes depending of Caveolae and/or Caveolins. Nano-drug could play an important role in drug delivery in sites where conventional ART have limited access, so as to achieve sufficient concentrations to execute optimal therapeutic responses and virus eradication in anatomical and intracellular sites.
